Figure 4

Flowchart of the study. pMHTN primary malignant hypertension, SDS-PAGE sodium sodecy sulfate polyacrylamide gel electrophoresis, LC–MS/MS liquid chromatography-tandem mass spectrometry, ELISA enzyme-linked immunosorbent assay, DEPs differentially expressed proteins, CFD complementary factor D, CAF C-terminal Agrin fragment, RBP4 retinol-binding protein 4, ROC receiver operating characteristic.